Mobile

Study conducted on humans in Europe to test the importance of a small molecule normally produced by the body, called Interleukin 2 (IL-2) to treat a specific type of diabetes (called type 1 diabetes)

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-002522-12

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

1. To evaluate efficacy of ILT-101 for the preservation of residual pancreatic β cells function 2. To select the optimal regimen of administration of ILT- 101

Critère d'inclusion

  • type -I diabetes

Liens